Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department www.aids.gov.br July 23th, 2014 TasP – Leadership.

Slides:



Advertisements
Similar presentations
The Brazilian Response to AIDS Mauro Teixeira de Figueiredo Head of the Division for Technical Cooperation International Advisory Ministry of Health Main.
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
HIV in Europe Stockholm, 3.November 2009 Communication on combating HIV/AIDS in the EU and the neighbourhood - strategy and second action plan ( )
The 2013 Consolidated WHO Guidelines on ARV Use: Implementing to Achieve Maximum Impact Gottfried Hirnschall, MD, MPH Director, HIV/AIDS Department, WHO.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
TB and HIV: Tightly Linked… and Why We Should Care.
ART: The Basics William Aldis World Health Organization Bangkok, September 14, 2005.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
MONITORING SYSTEM FOR THE ANTIRETROVIRAL THERAPY IN BRAZIL: LESSONS LEARNED AND FUTURE DIRECTIONS Marco Vitória, MD Brazilian STD/AIDS Programme - MOH.
Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 20th, 2014 Evidence.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation J2J Global Media Training on HIV/AIDS July 14, 2010 Vienna, Austria.
Prevention of Mother-to-Child Transmission of HIV in Ghana
HIV/AIDS Prevention and Care Nancy S. Padian, PhD, MPH Professor, Obstetrics, Gynecology & Reproductive Sciences Associate Director for Research, Global.
THE RESPONSE TO HIV/AIDS AND THE WORLD OF WORK IN BRAZIL Paulo R. Teixeira, MD Brazilian STD/AIDS Program Ministry of Health.
Technical Advisory Group meeting, WHO/WPRO
1988 Constitution: landmark for health The Unified Health System (SUS) UNIVERSALITY – as a fundamental right INTEGRALITY – from prevention to treatment.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Dr. Yogan Pillay Deputy Director General National Department of Health, South Africa Monday 1 July 2013 OPERATIONAL AND PROGRAMMATIC CONSIDERATIONS IN.
Module 7: Malaria and HIV/AIDS Palliative Care for People Living with HIV/AIDS.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Implications for Countries: Critical Issues in Service Delivery and Decision Making Dr. Yogan Pillay Deputy.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
Global Strategy, Policy and Normative Guidance for POC Diagnostics Gottfried Hirnschall MD, MPH Department of HIV/AIDS, World Health Organization July.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
HIV in Suriname Ministry of Health Suriname M.Sigrid Mac Donald – Ottevanger, MD Focal point HIV Treatment and Care, NAP.
Surveillance to measure impact of ART Theresa Diaz, MD MPH CDC Global AIDS Program.
Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.
Prevention with Positives; Using Multiple Strategies to Involve Persons Living with HIV in Prevention. TASO Uganda. Emmanuel Odeke,
Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.
Application of Patients’ Rights in Cross-Border Health Care Regional meeting and workshop February 2009 Budapest ŠKUC – Magnus, SLOVENIA Miran Šolinc.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Translating the Vision Towards Universal Access Dr Zengani Chirwa.
The Strategic Use of ARVs | IAC Satellite, July 22, |1 | Strategic Use of Antiretroviral Drugs WHO Perspective for Future Guidelines Chair of WHO.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents Summary of WHO Rapid Advice December 2009 Source: WHO HIV/AIDS Department.
Center for Health Policy Health Inequalities Program Duke University Beth Stringfield.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Division of HIV/AIDS Prevention CDC-RFA-PS
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
IAS Policy and Advocacy priority on Treatment as Prevention Carlos F. Cáceres Multidisciplinary Research on ARV-based Prevention 30 June 2013 Kuala Lumpur.
Haileyesus Getahun Stop TB Department WHO Re-conceptualizing ICF and IPT: global progress to date 14 th Core Group Meeting of the TB/HIV Working Group,
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
Treatment as Prevention and Treatment 2.0 Update UN Forum on AIDS, 24 June 2011 Nicole Seguy, Zhang Lan, WHO.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
Ministry of Health Health Surveillance Secretariat NATIONAL STD/AIDS PROGRAMME.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
WORLD AIDS DAY Zero new HIV infections Zero discrimination Zero AIDS-related deaths.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
STRATEGIC INFORMATION FOR ACTION IN VIET NAM 6 th Viet Nam National Scientific Conference 24 November 2015 Ha Noi, Viet Nam Amitabh Bipin SUTHAR, PharmD,
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
Global HIV Epidemiology Carey Farquhar, MD, MPH Grace John-Stewart MD, PhD Departments of Medicine, Epidemiology and Global Health.
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
Cost-effectiveness of initiating and monitoring HAART based on WHO versus US DHHS guidelines in the developing world Peter Mazonson, MD, MBA Arthi Vijayaraghavan,
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
3rd International HIV/Viral Hepatitis Co-Infection Meeting HIV/Viral Hepatitis: Improving Diagnosis, Antiviral Therapy and Access Sunday, 17 July.
HIV and AIDS The management of HIV and AIDS is an ongoing challenge for Anglo companies operating in countries with a high burden of HIV disease Strategy.
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
INPUT OF PMTCT TO ZERO NEW HIV INFECTION-CAMPAIGN IN RWANDA: Case of MUHIMA District Hospital By NTACYABUKURA Blaise, University of Rwanda, college of.
Expanding ARV treatment in developing countries: Issues and Prospects
Utilizing research as an opportunity to strengthen
Charles Gilks HIV Department, WHO
HIV.
PrEP in Brazil: 18 months of implementation as a public health policy
Presentation transcript:

Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 23th, 2014 TasP – Leadership perspective The Brazilian Ongoing Experience

HIV Prevalence Rate

Aids Detection Rate SOURCE: The Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department (MS/SVS/Departamento de DST, Aids e Hepatites Virais) (1) Cases notified in SINAN and registered in SISCEL/SICLOM by June and declared in the 2000 – 2011 SIM Preliminary data Detection Rate Year Brazil North Northeast Southeast South Midwest

HIV/Aids in Brazil  Deaths due to AIDS, annual average: 12,000 15,000, considering 30% due to underreporting and misreporting

What have we learned? We were relatively successful in controlling the epidemic, but were finding it hard to move on Need to strengthen and redirect the national response How? Evidence Based Decision Innovation Creativity

Classic Prevention Condoms Harm Reduction

Enabling Environment

Treatment as Prevention “The results have galvanized efforts to eliminate the global AIDS epidemic” Dr. Bruce Alberts, editor of Science magazine

New Testing Algorithms NEW GOVERNMENT DIRECTIVE (DECEMBER 2013) It introduces five new algorithms aimed at increasing access to testing and diagnosis  Algorithm 1: screening + confirmation -> RT finger prick  Algorithm 2: screening RT finger prick + confirmation Oral Fluid  Algorithm 3: screening 3rd generation immunoassays + confirmation VIRAL LOAD quantification  Algorithm 4: 4th generation immunoassays as screening + confirmation VIRAL LOAD quantification  Algorithm 5: combines 3rd generation immunoassay screening followed by Western Blot/Imunoblot confirmatory test

FOCUS on Key Population Focus on Key Populations  60 financed projects  Use of screening with oral fluid RT technology  4 populations: Trans Gay and other MSM PUD SW  4567 people tested by July 11

New Treatment Protocol The new Clinical Protocol and Therapeutic Guidelines (CPTG) for Treatment of the HIV Infection in Adults was discussed with an Advisory Board of experts, submitted to public consultation for 30 days, and published by Government Directive no. 27, on November 29, CPTG is available at: - (pdf and html) -Apple stores and Google Play (App)

New Treatment Protocol One of the highlights amongst the CPTG’s main new items is a recommendation to initiate antiretroviral therapy for all HIV positive people, regardless of CD4, based on the possible impact on morbidity and mortality, but also on the reduction of HIV transmission. A Public Health Approach. Brazil was the first developing country and the third country in the world to use treatment as prevention for all people with HIV and in its national recommendations.

Use of fixed recommended dose for first-line preferred regimen: TDF + 3TC + EFV

Expansion of HIV Management to Primary Care At the beginning of the AIDS epidemic: -High morbimortality – “AIDS- deaths” -Few drugs available -Many pills a day -Many side effects -Low treatment success -HIV as acute disease Specialized services Specialists Presently: -Decrease in mortality, increased survival -Many treatment options -Few pills a day -Few side effects -High treatment success -HIV as chronic disease New care model Participation of Primary Care and Specialist Services in caring for PLWHA

Our goal for 2014: at least 100 thousand more people in treatment New PLWHA on ART in the first semester of each year. Brazil, : a 30% increase, approximately, when compared to the same period in 2013

In 2014, the CD4 counts of 40% of the patients who began treatment was greater than 500 Distribution of individuals who began ART according to CD4 counts carried out 6 months earlier at most, by year of beginning in Brazil, * (*) Up to June 2014.

TasP is integrated with other strategies for a new treatment policy in Brazil TREATMENT 2.0 Adapt delivery systems Mobilize communities POC and other simplified monitoring Optimize drug regimens Reduce costs Combined fixed doses VIVA MELHOR SABENDO New diagnosis algorithms New treatment protocol – lines of treatment HIV Management in Primary Care

90 / 90 / 90: a Latin America Goal

90%

90 / 90 / 90: a Latin America Goal Jun/14 90%